BA
LMAT icon

Bridgewater Associates’s LeMaitre Vascular LMAT Stock Holding History

Bridgewater Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,353
Closed -$217K – 745
2024
Q4 		$217K Sell
2,353
-5,730
-71% -$551K ﹤0.01% 670
2024
Q3 		$751K Sell
8,083
-15,389
-66% -$1.33M ﹤0.01% 637
2024
Q2 		$1.93M Buy
23,472
+5,019
+27% +$369K 0.01% 540
2024
Q1 		$1.22M Sell
18,453
-2,948
-14% -$182K 0.01% 553
2023
Q4 		$1.21M Sell
21,401
-2,235
-9% -$117K 0.01% 608
2023
Q3 		$1.29M Buy
23,636
+1,968
+9% +$117K 0.01% 570
2023
Q2 		$1.46M Sell
21,668
-2,279
-10% -$139K 0.01% 517
2023
Q1 		$1.23M Buy
23,947
+975
+4% +$47.3K 0.01% 535
2022
Q4 		$1.06M Sell
22,972
-7,863
-26% -$368K 0.01% 637
2022
Q3 		$1.56M Buy
30,835
+94
+0.3% +$4.7K 0.01% 610
2022
Q2 		$1.4M Buy
30,741
+2,803
+10% +$125K 0.01% 748
2022
Q1 		$1.3M Buy
27,938
+6,584
+31% +$295K 0.01% 765
2021
Q4 		$1.07M Buy
21,354
+2,402
+13% +$124K 0.01% 560
2021
Q3 		$1.01M Buy
+18,952
New +$1.07M 0.01% 518

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bridgewater Associates's LMAT Position: Q1 2025 in Review

Bridgewater Associates sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 2,353 shares — an estimated $217K sold.

Bridgewater Associates first reported a position in LMAT in Q3 2021 and held it in 14 quarters. The position peaked at $1.93M in Q2 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Bridgewater Associates reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 2,353 LeMaitre Vascular shares in Q1 2025, an estimated $217K.
  • Bridgewater Associates first reported a position in LeMaitre Vascular in Q3 2021 and held it in 14 quarters.
  • Bridgewater Associates's LeMaitre Vascular position peaked at $1.93M in Q2 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.